https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
As of 15 August 2020, Coronavirus disease 2019 (COVID-19) has been reported in 21 million people world-wide and is responsible for more than 750,000 deaths. The occurrence of acute kidney injury (AKI) in patients hospitalized with COVID-19 has been reported to be as high as 43%. This is comparable to AKI in other forms of pneumonia requiring hospitalization, as well as in non-infectious conditions like cardiac surgery. The impact of AKI on COVID-19 outcomes is difficult to assess at present but, similar to other fo
إعجاب
علق
شارك
